Identification of reliable biomarkers in multiple sclerosis patients would be highly desirable to help disease activity and progression monitoring, and evaluate response to treatments. The field has gradually shifted from the aim to find the perfect surrogate marker to the construction of composite markers with higher performances, taking advantage of the technologies allowing unbiased screening (i.e., microarrays, proteomics, etc.). Despite the fact that very interesting results have been produced, no approach has yet made it to the patient's bedside.
Definition of non-responders: biological markers / Furlan, R. - In: NEUROLOGICAL SCIENCES. - ISSN 1590-1874. - 29:(2008), pp. 214-215. [10.1007/s10072-008-0940-3]
Definition of non-responders: biological markers
Furlan R
Primo
2008-01-01
Abstract
Identification of reliable biomarkers in multiple sclerosis patients would be highly desirable to help disease activity and progression monitoring, and evaluate response to treatments. The field has gradually shifted from the aim to find the perfect surrogate marker to the construction of composite markers with higher performances, taking advantage of the technologies allowing unbiased screening (i.e., microarrays, proteomics, etc.). Despite the fact that very interesting results have been produced, no approach has yet made it to the patient's bedside.| File | Dimensione | Formato | |
|---|---|---|---|
|
s10072-008-0940-3.pdf
solo gestori archivio
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Copyright dell'editore
Dimensione
32.84 kB
Formato
Adobe PDF
|
32.84 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
